TAVR vs. surgery, FFR-guided PCI and DCB safety: Day 3 at ACC.22

Read our in-person coverage of the final day of ACC.22.

Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD.

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time. 

Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

Depression linked to a higher stroke risk among heart attack survivors

The new findings, based on data from nearly 500,000 patients, were presented during ACC.22.

Women less likely to receive treatment, more likely to die after cardiogenic shock

Emerging data about differences in treatment for women and men may shed light on diverging outcomes.

Thumbnail

ACC health policy statement calls out negative work environments in cardiology

The statement offers resources and tools to combat bias, discrimination, bullying, and harrassment.

Ami Bhatt, MD, the American College of Cardiology (ACC) Chief Innovation Officer, and an Adult Congenital Heart Disease cardiologist at Mass General Hospital (MGH). She is viewed one of the national experts on telecardiology, having been the former director of telecardiology at Mass General during 2020-2021.

VIDEO: American College of Cardiology working to propel cardiovascular innovation

Ami Bhatt, MD, explained how the ACC is working to advance new technologies that can improve patient care.